CERENE JAMES: Open Payments
NPI 1609535558 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$190 in 10 payments from 4 companies in 2025. Trend: 2023 $38 · 2024 $70 · 2025 $190
Food & beverage: $190
| Company | Payments | Amount |
|---|---|---|
| QOL Medical, LLC | 3 | $53 |
| Alcresta Therapeutics, Inc. | 2 | $49 |
| Celltrion USA Inc. | 3 | $45 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $42 |
Products named: Sucraid, RELIZORB, VEGZELMA, EOHILIA.
Industry payments across CA — which companies pay providers there.
